1. Home
  2. IOVA vs LNC Comparison

IOVA vs LNC Comparison

Compare IOVA & LNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$14.11

Market Cap

6.7B

Sector

Health Care

ML Signal

HOLD

Logo Lincoln National Corporation

LNC

Lincoln National Corporation

HOLD

Current Price

$40.90

Market Cap

7.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
LNC
Founded
2007
1905
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
7.0B
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
IOVA
LNC
Price
$14.11
$40.90
Analyst Decision
Buy
Hold
Analyst Count
10
13
Target Price
$14.40
★ $47.83
AVG Volume (30 Days)
★ 12.5M
1.6M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 4.46%
EPS Growth
★ 14.84
N/A
EPS
N/A
★ 5.65
Revenue
N/A
★ $18,212,000,000.00
Revenue This Year
$56.63
$8.34
Revenue Next Year
$42.41
$3.80
P/E Ratio
★ N/A
$7.18
Revenue Growth
★ N/A
N/A
52 Week Low
$1.76
$32.18
52 Week High
$15.37
$47.67

Technical Indicators

Market Signals
Indicator
IOVA
LNC
Relative Strength Index (RSI) 59.41 49.30
Support Level $3.57 $38.83
Resistance Level $15.00 $42.68
Average True Range (ATR) 0.92 0.99
MACD -0.17 0.08
Stochastic Oscillator 58.17 48.87

Price Performance

Historical Comparison
IOVA
LNC

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About LNC Lincoln National Corporation

Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability, and dental.

Share on Social Networks: